1. Extend your firm’s global presence by leveraging the LSN worldwide investor partnering network across the silos of drugs, devices, diagnostics and digital health in the early-stage life science arena.
2. Increase exposure and reach of your products and services to hundreds of early-stage companies who are your target clients. Over 2,000 scientists-entrepreneurs and fundraising CEOs participate in the RESI Conference Series.
3. Gain partnering access to start-up CEOs and investors with compelling life science portfolios.
4. Unique promotion through LSN web entities, newsletter and social media accounts before, during, and after the event.